These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

743 related items for PubMed ID: 22943930

  • 1. Efficacy and tolerability of diphenyl-dimethyl-dicarboxylate plus garlic oil in patients with chronic hepatitis.
    Lee MH, Kim YM, Kim SG.
    Int J Clin Pharmacol Ther; 2012 Nov; 50(11):778-86. PubMed ID: 22943930
    [Abstract] [Full Text] [Related]

  • 2. Garlic oil and DDB, comprised in a pharmaceutical composition for the treatment of patients with viral hepatitis, prevents acute liver injuries potentiated by glutathione deficiency in rats.
    Park EY, Ki SH, Ko MS, Kim CW, Lee MH, Lee YS, Kim SG.
    Chem Biol Interact; 2005 Jun 30; 155(1-2):82-96. PubMed ID: 15950962
    [Abstract] [Full Text] [Related]

  • 3. Serum markers for necroinflammatory activity in patients with chronic viral hepatitis and normal or mildly elevated aminotransferase levels.
    Cheong JY, Kim DJ, Hwang SG, Yang JM, Kim YB, Park YN, Cho SW.
    Liver Int; 2011 Oct 30; 31(9):1352-8. PubMed ID: 21745311
    [Abstract] [Full Text] [Related]

  • 4. DDB treatment of patients with chronic hepatitis.
    Huber R, Hockenjos B, Blum HE.
    Hepatology; 2004 Jun 30; 39(6):1732-3. PubMed ID: 15185315
    [Abstract] [Full Text] [Related]

  • 5. [Differential liver histopathological features of chronic HBV infection patients with normal and mildly elevated serum ALT].
    Ying RS, Yang Z, Chen YY, Yang KL, Xiao YH, Wu LJ, Fan HM.
    Zhonghua Gan Zang Bing Za Zhi; 2012 Aug 30; 20(8):585-8. PubMed ID: 23207151
    [Abstract] [Full Text] [Related]

  • 6. Phase II clinical trial of combined natural interferon-beta plus recombinant interferon-gamma treatment of chronic hepatitis B.
    Musch E, Högemann B, Gerritzen A, Fischer HP, Wiese M, Kruis W, Malek M, Gugler R, Schmidt G, Huchzermeyer H, Gerlach U, Dengler HJ, Sauerbruch T.
    Hepatogastroenterology; 1998 Aug 30; 45(24):2282-94. PubMed ID: 9951911
    [Abstract] [Full Text] [Related]

  • 7. Oral silymarin for chronic hepatitis C - a retrospective analysis comparing three dose regimens.
    Huber R, Futter I, Lüdtke R.
    Eur J Med Res; 2005 Feb 28; 10(2):68-70. PubMed ID: 15817425
    [Abstract] [Full Text] [Related]

  • 8. [Magnesium isoglycyrrhizinate in the treatment of chronic liver diseases: a randomized, double-blind, multi-doses, active drug controlled, multi-center study].
    Mao YM, Zeng MD, Chen Y, Chen CW, Fu QC, Cai X, Wu SM, Chen YG, Sun Y, Li J, Sui YH, Zhao W, Lu LG, Cao AP, Chen HZ.
    Zhonghua Gan Zang Bing Za Zhi; 2009 Nov 28; 17(11):847-51. PubMed ID: 19958646
    [Abstract] [Full Text] [Related]

  • 9. [Investigation of oxidative stress and antioxidant defense in patients with hepatitis B virus infection and the effect of interferon-alpha plus lamivudine combination therapy on oxidative stress].
    Acar A, Görenek L, Aydin A, Eyigün CP, Eken A, Sayal A, Pahsa A.
    Mikrobiyol Bul; 2009 Jul 28; 43(3):411-23. PubMed ID: 19795616
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Comparison on the efficacy and safety of biphenyl dimethyl dicarboxylate and ursodeoxycholic acid in patients with abnormal alanine aminotransferase: multicenter, double-blinded, randomized, active-controlled clinical trial].
    Lee SH, Cheon GJ, Kim HS, Kim YD, Kim SG, Kim YS, Jeong SW, Jang JY, Kim BS.
    Korean J Gastroenterol; 2014 Jul 28; 64(1):31-9. PubMed ID: 25073669
    [Abstract] [Full Text] [Related]

  • 12. Does Silybum marianum play a role in the treatment of chronic hepatitis C?
    Torres M, Rodríguez-Serrano F, Rosario DJ, Rodríguez-Perez F, Toro DH.
    P R Health Sci J; 2004 Jun 28; 23(2 Suppl):69-74. PubMed ID: 16929590
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Decreased serum aminotransferase activity in patients with chronic renal failure: impact on the detection of viral hepatitis.
    Fabrizi F, Lunghi G, Finazzi S, Colucci P, Pagano A, Ponticelli C, Locatelli F.
    Am J Kidney Dis; 2001 Nov 28; 38(5):1009-15. PubMed ID: 11684554
    [Abstract] [Full Text] [Related]

  • 15. A randomized double-blind placebo-controlled study of lamivudine in the treatment of patients with chronic hepatitis B virus infection.
    Yao G, Wang B, Cui Z, Yao J, Zeng M.
    Chin Med J (Engl); 1999 May 28; 112(5):387-91. PubMed ID: 11593504
    [Abstract] [Full Text] [Related]

  • 16. Dietary amino acid taurine ameliorates liver injury in chronic hepatitis patients.
    Hu YH, Lin CL, Huang YW, Liu PE, Hwang DF.
    Amino Acids; 2008 Aug 28; 35(2):469-73. PubMed ID: 17690950
    [Abstract] [Full Text] [Related]

  • 17. Clinical trial: the efficacy and safety of oral PF-03491390, a pancaspase inhibitor - a randomized placebo-controlled study in patients with chronic hepatitis C.
    Shiffman ML, Pockros P, McHutchison JG, Schiff ER, Morris M, Burgess G.
    Aliment Pharmacol Ther; 2010 May 28; 31(9):969-78. PubMed ID: 20163376
    [Abstract] [Full Text] [Related]

  • 18. Higher efficacy of sequential therapy with interferon-alpha and lamivudine combination compared to lamivudine monotherapy in HBeAg positive chronic hepatitis B patients.
    Sarin SK, Kumar M, Kumar R, Kazim SN, Guptan RC, Sakhuja P, Sharma BC.
    Am J Gastroenterol; 2005 Nov 28; 100(11):2463-71. PubMed ID: 16279901
    [Abstract] [Full Text] [Related]

  • 19. Two-year lamivudine treatment for hepatitis B e antigen-negative chronic hepatitis B: a double-blind, placebo-controlled trial.
    Chan HL, Wang H, Niu J, Chim AM, Sung JJ.
    Antivir Ther; 2007 Nov 28; 12(3):345-53. PubMed ID: 17591024
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.